RNA editing: emerging from CRISPR’s shadow
Bio Pharma Dive
OCTOBER 22, 2024
Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.
ALS drugs from Denali, Calico come up short, marking more failures for Healey trial
Bio Pharma Dive
JANUARY 7, 2025
Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.
Life Science 
321
321 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xtalks Life Science Podcast: Celebrating 200 Episodes of Industry Innovation
XTalks
MARCH 19, 2025
This week, were celebrating a significant milestone: the release of our 200th episode of the Xtalks Life Science Podcast ! We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of life sciences.
Life Science 52
52 
Abu Dhabi DoH signs new deal to accelerate development in life sciences
Pharmaceutical Technology
JUNE 16, 2023
The Abu Dhabi Department of Health (DoH) in the UAE has made a declaration of collaboration with Mass General Brigham’s (MGB) International Center for Genetic Disease (iCGD) to advance life sciences.
Life Science 130
130 
Verix boosts life science AI capabilities with start-up.ai acquisition
Pharmaceutical Technology
JUNE 16, 2023
for an undisclosed sum, boosting its life science AI capabilities. The deal enables Verix to further improve its capacities to use AI to advance the brand growth of life science companies. Using these data, pharma firms can also ensure that the right medicines will be available to the right patients at the right time.
Life Science 130
130 
Report highlights challenges facing life sciences sector amid economic turbulence
Outsourcing Pharma
MAY 9, 2024
A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.
Life Science 95
95 
Celebrating Black History Month: Black Scientists that Have Revolutionized the Life Sciences
XTalks
FEBRUARY 15, 2024
In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. They serve as inspiration for future generations of scientists from all backgrounds.
Life Science 115
115 
Khosla Ventures’ Alex Morgan on biotech’s challenges and solving drug delivery
Bio Pharma Dive
FEBRUARY 6, 2024
The life sciences investor has backed a number of startups working on technologies for delivering and manufacturing cell and gene medicines.
Drug Delivery 208
208 
Life Science Trends to Look Out for in 2024
XTalks
DECEMBER 20, 2023
As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.
Life Science 119
119 
Exploring the Endocannabinoid System for Drug Development, Featuring Punit Dhillon, Chairman & CEO of Skye Bioscience – Xtalks Life Science Podcast Ep. 144
XTalks
JANUARY 31, 2024
Punit Dhillon, Chairman & CEO Skye Bioscience Punit brings two decades of experience as a leader and investor within the life sciences sector. The company is aiming to unlock the medicinal possibilities of the endocannabinoid system for addressing diseases that lack adequate treatments for patients globally.
Life Science 116
116 
Reaching New Global ‘Frontiers’ In Life Sciences
Intouch Solutions
NOVEMBER 16, 2023
The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare.
Life Science 105
105 
Foresite Raises $900M in Sixth Fund to Invest in Life Science Startups
BioSpace
JUNE 12, 2024
Among the biggest raises this year, Foresite Capital’s $900 million fund will support biotech companies working in precision medicine and life science infrastructure.
Life Science 84
84 
Looking at Women’s Leadership in Life Science Industries on International Women’s Day
XTalks
MARCH 8, 2022
On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation.
Life Science 105
105 
Blueprint Medicines announces financing partnerships for $1.25bn
Pharmaceutical Technology
JULY 1, 2022
Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. Under the deal, Blueprint Medicines will receive an upfront cash payment of $175m as well as up to $165m in potential milestone payments contingent on sales in the future.
Medicine 147
147 
Cell Therapies for Chronic Kidney Disease: Featuring Bruce Culleton, CEO, ProKidney – Xtalks Life Science Podcast Ep. 153
XTalks
APRIL 3, 2024
Before beginning his career in industry in 2007, Dr. Culleton was a Clinical Associate Professor in the Department of Medicine at the University of Calgary. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. If you want your company to be featured on Xtalks.com, please email ayeshar@xtalks.com.
Life Science 105
105 
Merck reports rise in group net sales in fiscal 2022
Pharmaceutical Technology
MARCH 2, 2023
The growth in sales was driven by all regions and business sectors, particularly Life Science. to €10.38bn in its Life Science business during the year. The EBITDA pre of Life Science grew by 14.4% The increase in sales was due to new medicines. to €22.23bn in fiscal 2022 against €19.68bn in 2021.
Sales 245
245 
Insights into Precision Dosing with Dr. Howard McLeod and Dr. Sharmeen Roy – Xtalks Life Science Podcast Ep. 163
XTalks
JUNE 12, 2024
Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Tune into the episode to learn more about the current landscape of precision dosing, including the latest technologies and tools designed to help optimize drug dosages. If you want your company to be featured on Xtalks.com, please email ayeshar@xtalks.com.
Life Science 97
97 
Cognizant and Boehringer Ingelheim partner to speed delivery of new medicines
Pharmaceutical Technology
APRIL 12, 2023
Cognizant and Boehringer Ingelheim are collaborating on an integrated cloud platform to enhance the speed and quality of medicinal therapy development. Cognizant will leverage the Veeva Development Cloud platform to help Boehringer Ingelheim to merge medicinal development processes and data into a connected technology ecosystem.
Medicine 130
130 
Call to arms as UK falls back in medicines manufacturing
pharmaphorum
JANUARY 24, 2023
Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Medicines and medical technology manufacturing delivered annual exports worth over £30 billion ($37 billion) for the UK in 2019, on top of making a £32.1 It’s not all bad news.
Manufacturing 111
111 
Novel Approaches in Cancer Immunotherapy — Featuring OncoC4 founder, CEO and CSO Dr. Yang Liu and CFO Abid Ansari – Xtalks Life Science Podcast Ep. 146
XTalks
FEBRUARY 14, 2024
Abid Ansari, MBA Chief Financial Officer OncoC4 Abid Ansari is a finance executive with a more 20-year track record in the life sciences industry encompassing corporate finance, fundraising, business development and investor relations experiences for public and private life science companies.
Life Science 119
119 
Exploring Next Generation Chemotherapy Drugs with Processa Pharma’s Dr. David Young – Xtalks Life Science Podcast Ep. 126
XTalks
SEPTEMBER 6, 2023
Learn about Processa’s regulatory science approach to drug development and the changing landscape of cancer treatment. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.
Life Science 116
116 
A new frontier: Skin cell study looks at regenerative medicine in space
Medical Xpress
APRIL 6, 2023
director of the Wound Healing and Regenerative Medicine Research Program at the University of Miami Miller School of Medicine, were launched to the International Space Station for advanced testing as part of a research voyage by CUTISS, a Swiss life sciences company.
Medicine 103
103 
Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals
pharmaphorum
OCTOBER 28, 2022
In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,
Medicine 122
122 
Interview with BriaCell’s CEO Dr. William Williams– Xtalks Life Science Podcast Ep. 124
XTalks
AUGUST 23, 2023
Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Williams about BriaCell’s novel cell therapies for cancer and what the future of immunotherapy and personalized treatments may look like.
Life Science 98
98 
Advancements in Blood-Based Biomarker Tests for NASH — Interview with Dr. Tania Kamphaus and Tony Villiotti – Xtalks Life Science Podcast Ep. 128
XTalks
SEPTEMBER 20, 2023
The research, published in Nature Medicine , presents results from a study that evaluated blood-based biomarker tests for the diagnosis of NASH. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Life Science 111
111 
Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allergan Aesthetics – Xtalks Life Science Podcast Ep. 134
XTalks
NOVEMBER 1, 2023
Allergan Aesthetics is focused on creating products and technologies that drive the advancement of aesthetic medicine. Dr. Manson Brown’s Clinical Development and Scientific Innovation team are responsible for global clinical trial development strategy for the Aesthetic Medicine portfolio, covering pharmaceuticals and device.
Life Science 105
105 
The State of Infectious Diseases: New Trivalent Flu Vaccine and More ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore – Xtalks Life Science Podcast Ep. 158
XTalks
MAY 8, 2024
In this episode, Ayesha spoke with William Schaffner, MD, Professor of Preventive Medicine Health Policy and Professor in the Division of Infectious Diseases at Vanderbilt University; and Kelly Moore, MD, MPH, President and CEO at Immunize.org and Associate Professor of Health Policy at Vanderbilt University.
Life Science 101
101 
Bimodal Neuromodulation for Tinnitus: Interview with Caroline Hamilton, Clinical Director of Neuromod Devices – Xtalks Life Science Podcast Ep. 81
XTalks
OCTOBER 12, 2022
Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Hear more about Neuromod’s Lenire device, including clinical and real-world data showing its effectiveness in improving symptoms of tinnitus.
Life Science 98
98 
Not-for-profit alliance advocates for greater collaboration in life sciences
Outsourcing Pharma
JANUARY 29, 2024
The Pistoia Alliance has published its Identification of Medicinal Products (IDMP) Ontology 1.0 under an open-source license.
Life Science 98
98 
Alkeus raises funds to launch Stargardt disease therapy gildeuretinol
Pharmaceutical Technology
JUNE 6, 2023
Led by Bain Capital Life Sciences, the financing round has also seen participation from Sofinnova Investments, TCGX and Wellington Management. Gildeuretinol is the first and only medicine in clinical development to treat Stargardt disease by reducing vitamin A dimerization in the eye, without affecting normal vision.
Genetics 279
279 
In conversation with FNIH’s Dr. Courtney Silverthorn, Director of the AMP Bespoke Gene Therapy Consortium, About New Rare Disease Trial Portfolio – Xtalks Life Science Podcast Ep. 114
XTalks
JUNE 14, 2023
This episode features an interview with Dr. Courtney Silverthorn who is an Associate Vice President at the Foundation for the National Institutes of Health (FNIH) and the Director of the Accelerating Medicines Partnership (AMP) program including the Bespoke Gene Therapy Consortium.
Gene Therapy 98
98 
Advancements in Blood-Based Biomarker Tests for NASH — Interview with Dr. Tania Kamphaus and Tony Villioti – Xtalks Life Science Podcast Ep. 128
XTalks
SEPTEMBER 20, 2023
The research, published in Nature Medicine , presents results from a study that evaluated blood-based biomarker tests for the diagnosis of NASH. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Life Science 98
98 
The ins and outs of the life sciences: top hires for October 2022
pharmaphorum
NOVEMBER 7, 2022
“Jill is a wonderful addition to our executive team as we work to establish Lineage as a leader in cell therapy and cell transplant medicine,” stated Brian M Culley, Lineage CEO. ” The post The ins and outs of the life sciences: top hires for October 2022 appeared first on.
Life Science 105
105 
Crossed wires? Mixed messages on medicines
pharmaphorum
JANUARY 20, 2023
Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines. For that, the government has set out the Life Sciences Vision , published back in July 2021.
Medicine 105
105 
US FDA approves GSK’s Jesduvroq to treat anaemia of CKD
Pharmaceutical Technology
FEBRUARY 2, 2023
The European Medicines Agency is currently reviewing a marketing authorisation application for daprodustat and a regulatory decision is expected in the first half of this year. In June 2020, Japan’s Ministry of Health, Labour and Welfare approved daprodustat tablets to treat patients with anaemia of CKD.
FDA Approval 264
264 
Bringing the Tech Revolution to Medicine with Digital Therapeutics ft. Click Therapeutics’ CMO Dr. Shaheen Lakhan — Xtalks Life Science Podcast Ep. 184
XTalks
NOVEMBER 13, 2024
Dr. Lakhan, is an inventive entrepreneurial physician-scientist who is board-certified in neurology and pain medicine with over 20 years of industry experience. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. If you want your company to be featured on Xtalks.com, please email ayeshar@xtalks.com.
Life Science 59
59 
Aviceda, QUB to develop next-generation glyco-immune therapeutics
Pharmaceutical Technology
APRIL 10, 2023
The HALOS platform is built using an invention from the research team led by Professor Chris Scott, who is the scientific co-founder and chief scientific officer of Aviceda and interim dean of research, faculty of medicine, health, and life sciences, at Queen’s.
Development 259
259 
Report warns economic instability has hit UK drug discovery
pharmaphorum
MAY 9, 2024
A UK report has said that inflation and geopolitical instability have led to a “dramatic drop” in investment in smaller companies developing new medicines, with a knock-on effect on the entire life sciences industry.
Life Science 119
119 
Similis Bio plans to partner with Novel351k for biosimilars development
Pharmaceutical Technology
FEBRUARY 15, 2023
JSR Life Sciences’ business unit Similis Bio is planning to collaborate with Novel351k for the development of three biosimilar programmes targeting cancer and autoimmune diseases. According to JSR Life Sciences, the therapies developed under the collaboration have more than $15bn current annual market value.
Development 147
147 
Investment fuels AI-driven development of breakthrough genomic medicines
pharmaphorum
OCTOBER 12, 2022
We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says. Genomic medicine is a rapidly growing space in which researchers use the information in a person’s genes to identify and administer medical treatment.”.
Genomics 105
105 
Moderna and IBM to explore quantum computing and AI for mRNA research
Pharmaceutical Technology
APRIL 21, 2023
IBM will also provide its knowledge to help Moderna explore the potential use cases of quantum technologies in life sciences. We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of quantum computing and ready our business for these game-changing technologies.
Research 246
246 
8 Best Cities In The US Offering Biotech Jobs
BioSpace
JULY 26, 2021
Biotech jobs are one of the most promising career paths for people who are into life sciences and those who dream of creating change in the world through developing breakthrough medicines and therapeutics.
Life Science 117
117 
Grifols’ Innovation Strategy in the Plasma Medicine Space
XTalks
DECEMBER 12, 2023
Plasma medicine is a critical and specialized field within healthcare, centering on the use of human plasma for the development and administration of life-saving treatments. When people think about innovation drivers in global healthcare, they often think of “big pharma,” and not necessarily companies in the plasma medicines space.
Medicine 111
111 
The downside of VC funding for biotech
World of DTC Marketing
JANUARY 24, 2022
Particularly attractive are medicines ahead of the curve, aimed at diseases likely to move into the spotlight over the next few years. A group of early-stage life science investors and biotech CEOs joined together with a prominent patient advocate to speak out against H.R.3, Only about $2.2
Life Science 225
225 
Let's personalize your content